홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

2,4-Dioxo-5-thiazolidineacetic acid → N-(3-tert-butylphenyl)-4-[1-[2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetyl]piperidin-4-yl]benzamide

HRID 678044
노트
인쇄 미리보기

반응식

HRID 678044 반응식
[C:1]([CH3:2])([CH3:3])([CH3:4])[c:5]1[cH:6][c:7]([NH:11][C:12]([c:13]2[cH:14][cH:15][c:16]([CH:19]3[CH2:20][CH2:21][NH:22][CH2:23][CH2:24]3)[cH:17][cH:18]2)=[O:25])[cH:8][cH:9][cH:10]1.[CH3:37][O:38][C:39]([CH:40]1[CH2:41][CH2:42][CH:43]([C:44]([N:45]2[CH2:46][CH2:47][N:48]([c:49]3[cH:50][cH:51][c:52]([C:53](=[O:54])[NH:55][c:56]4[cH:57][cH:58][cH:59][c:60]([C:61]([CH3:62])([CH3:63])[CH3:64])[cH:65]4)[cH:66][n:67]3)[CH2:68][CH2:69]2)=[O:70])[CH2:71][CH2:72]1)=[O:73].[O:26]=[C:27]1[S:28][CH:29]([CH2:33][C:34](=[O:35])[OH:36])[C:30](=[O:32])[NH:31]1>>[C:1]([CH3:2])([CH3:3])([CH3:4])[c:5]1[cH:6][c:7]([NH:11][C:12]([c:13]2[cH:14][cH:15][c:16]([CH:19]3[CH2:20][CH2:21][N:22]([C:34]([CH2:33][CH:29]4[S:28][C:27](=[O:26])[NH:31][C:30]4=[O:32])=[O:35])[CH2:23][CH2:24]3)[cH:17][cH:18]2)=[O:25])[cH:8][cH:9][cH:10]1
참가 물질출처 및 근거반응 노트

참가 물질

4

반응물 3

HCID 6450302,4-Dioxo-5-thiazolidineacetic acidHCID 59317976N-(3-tert-Butyl-phenyl)-4-piperidin-4-yl-benzamideHCID 593180854-{4-[5-(3-tert-Butyl-phenylcarbamoyl)-pyridin-2-yl]-piperazine-1-carbonyl}-cyclohexanecarboxylic acid methyl ester

생성물 1

HCID 59317987N-(3-tert-butylphenyl)-4-[1-[2-(2,4-dioxo-1,3-thiazolidin-5-yl)acetyl]piperidin-4-yl]benzamide

출처 및 근거

ORD 기록
ord-e5cdd19b923e419fb7a01a397b52b0a6
출처 데이터셋
Training data from https://doi.org/10.1039/C8SC04228D (3/10)
DOI
10.1039/C8SC04228D

반응 노트

불러오는 중…

이 페이지에서참가 물질출처 및 근거반응 노트